Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by RadientTechon Mar 23, 2018 11:02am

140 Views

Post# 27769793

RE:RE:Senior Management Getting Fat

LOL I did the same thing
Researched and couldnbt figure out who was investing in a couple greenhouses for rent
5000 pens to sell ina tent though that was a pretty big move ! investors here were like "holy smokes theyre sellign pens now at the county fair

if they start selling beaver tails im in

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!